Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» How the Actavis deal upended Allergan No. 2's CEO ambitions
How the Actavis deal upended Allergan No. 2's CEO ambitions
How the Actavis deal upended Allergan No. 2's CEO ambitions
Submitted by
admin
on February 4, 2015 - 9:58am
Source:
Yahoo/Reuters
News Tags:
Allergan
Amgen
M&A
Doug Ingram
Headline:
How the Actavis deal upended Allergan No. 2's CEO ambitions
Do Not Allow Advertisers to Use My Personal information
